Neurological symptoms and findings in COVID-19: a prospective clinical study
AuthorKöseoğlu Toksoy, Cansu
Şarlak Konya, Petek
Çoşğun, İbrahim Güven
Börü, Ülkü Türk
MetadataShow full item record
CitationKöseoğlu Toksoy, C., Yavuz, T., Orhan, S., Şarlak Konya, P., Korkmaz, D., Tünay, H., ... & Türk Börü, Ü. (2022). Neurological symptoms and findings in COVID-19: a prospective clinical study. Neurological Research, 44(1), 1-6.
Objective: We sought to evaluate neurologic symptoms and findings in patients with COVID- 19 infection hospitalized in a ward and intensive care unit (ICU). Methods: This study was designed as a prospective study. Hospitalized COVID-19 rRt-PCR positive patients in the ward and ICU were included in the study. A 54-item questionnaire was used to evaluate the patients. Patients were examined within 3 hours of hospitalization. Results: A total of 379 patients were included in the study. The mean age of the patients was 56.1 ± 17.8. 89 of the patients were in intensive care. At least one general symptom was recorded in 95.5% of patients. The most common neurologic symptoms were myalgia (48.5%), headache (39.6%), anosmia (34.8%), and dysgeusia (34%). Neurological symptoms in ICU patients were higher than in the ward. 53.6% of patients had comorbidities. Discussion: This study indicated that the prevalence of neurological symptoms was very high in patients with COVID-19. The percentage of neurological symptoms and findings was higher in patients hospitalized in ICU.